Deutsche Bank’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Deutsche Bank’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-456	Closed	-$15K	–	5021
2019 Q4	$15K	Buy	+456	New	+$13.6K	﹤0.01%	4393
2019 Q2	–	Sell	-1,200	Closed	-$20K	–	5601
2019 Q1	$20K	Buy	+1,200	New	+$18K	﹤0.01%	4796
2018 Q4	–	Sell	-6,900	Closed	-$114K	–	5523
2018 Q3	$114K	Buy	+6,900	New	+$104K	﹤0.01%	4454
2017 Q4	–	Sell	-2,600	Closed	-$49K	–	5215
2017 Q3	$49K	Buy	+2,600	New	+$49K	﹤0.01%	4374

Other funds holding ZEAL

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Deutsche Bank's ZEAL Position: Q1 2020 in Review

Deutsche Bank sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q1 2020, closing a stake of 456 shares — an estimated $15K sold.

Deutsche Bank first reported a position in ZEAL in Q3 2017 and held it in 4 quarters. The position peaked at $114K in Q3 2018. 19 funds tracked by Wall St. Rank hold ZEAL as of Q1 2020.

Deutsche Bank reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 456 Zealand Pharma A/S American Depositary Shares shares in Q1 2020, an estimated $15K.
Deutsche Bank first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 4 quarters.
Deutsche Bank's Zealand Pharma A/S American Depositary Shares position peaked at $114K in Q3 2018.
19 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.